| Sorafenib in advanced hepatocellular carcinoma JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ... New England journal of medicine 359 (4), 378-390, 2008 | 15605 | 2008 |
| Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ... Journal of Clinical Oncology 33 (6), 550-558, 2015 | 2500 | 2015 |
| From NASH to HCC: current concepts and future challenges QM Anstee, HL Reeves, E Kotsiliti, O Govaere, M Heikenwalder Nature reviews Gastroenterology & hepatology 16 (7), 411-428, 2019 | 1294 | 2019 |
| TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ... Nature communications 5 (1), 4309, 2014 | 743 | 2014 |
| Activation of hepatic stellate cells—a key issue in liver fibrosis HL Reeves, SL Friedman Front Biosci 7 (4), 808-826, 2002 | 738 | 2002 |
| Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team J Dyson, B Jaques, D Chattopadyhay, R Lochan, J Graham, D Das, ... Journal of hepatology 60 (1), 110-117, 2014 | 711 | 2014 |
| KLF6, a candidate tumor suppressor gene mutated in prostate cancer G Narla, KE Heath, HL Reeves, D Li, LE Giono, AC Kimmelman, ... Science 294 (5551), 2563-2566, 2001 | 620 | 2001 |
| Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma YL Liu, GL Patman, JBS Leathart, AC Piguet, AD Burt, JF Dufour, CP Day, ... Journal of hepatology 61 (1), 75-81, 2014 | 607 | 2014 |
| The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers PJ Johnson, SJ Pirrie, TF Cox, S Berhane, M Teng, D Palmer, J Morse, ... Cancer Epidemiology, Biomarkers & Prevention 23 (1), 144-153, 2014 | 327 | 2014 |
| A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis J Gautheron, M Vucur, F Reisinger, DV Cardenas, C Roderburg, C Koppe, ... EMBO molecular medicine 6 (8), 1062-1074, 2014 | 325 | 2014 |
| Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients S Berhane, H Toyoda, T Tada, T Kumada, C Kagebayashi, S Satomura, ... Clinical Gastroenterology and Hepatology 14 (6), 875-886. e6, 2016 | 312 | 2016 |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 294 | 2021 |
| Molecular pathogenesis and systemic therapies for hepatocellular carcinoma JM Llovet, R Pinyol, RK Kelley, A El-Khoueiry, HL Reeves, XW Wang, ... Nature cancer 3 (4), 386-401, 2022 | 277 | 2022 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 276 | 2017 |
| A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk G Narla, A DiFeo, HL Reeves, DJ Schaid, J Hirshfeld, E Hod, A Katz, ... Cancer research 65 (4), 1213-1222, 2005 | 270 | 2005 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 263 | 2019 |
| Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer HL Reeves, G Narla, O Ogunbiyi, AI Haq, A Katz, S Benzeno, E Hod, ... Gastroenterology 126 (4), 1090-1103, 2004 | 233 | 2004 |
| The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008 | 227 | 2008 |
| Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread G Narla, A DiFeo, S Yao, A Banno, E Hod, HL Reeves, RF Qiao, ... Cancer Research 65 (13), 5761-5768, 2005 | 205 | 2005 |
| Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1 S Benzeno, G Narla, J Allina, GZ Cheng, HL Reeves, MS Banck, JA Odin, ... Cancer research 64 (11), 3885-3891, 2004 | 205 | 2004 |
C DayNewcastle UniversityVerified email at ncl.ac.uk